Vitamin C Linked to Improved Outcomes in People with Precancerous Blood Disorders

New research reveals that vitamin C supplements may improve outcomes for patients with precancerous blood disorders by boosting TET enzymes, cellular proteins that control gene regulation. Since decreased TET enzyme function is a common driver of certain blood cancers, scientists investigated whether vitamin C supplementation could help patients at risk of developing these malignancies. This finding offers potential preventive benefits for individuals with myelodysplastic syndromes and similar conditions. The discovery opens new therapeutic avenues and highlights the importance of monitoring high-risk patients for possible intervention.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: September 21, 2026 at 10:01 AM



